The role of neuronal growth factors in neurodegenerative disorders of the human brain

Brain Research Reviews

Volumn 27, Issue 1, 1998, Pages 1-39

  Connor, B ^a,b   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

BDNF; GDNF; IGF I; Neurodegeneration; Neurotrophin; NGF; NT 3; TGF ; Trk Receptor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TYROSINE KINASE RECEPTOR;

ALZHEIMER DISEASE; AMNESIA; APOPTOSIS; CHOLINERGIC SYSTEM; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE SPROUTING; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROTROPHIN 3; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0032102110     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00004-6     Document Type: Review

References (500)

1. [1] A. Acheson, R.M. Lindsay, Non target-derived roles of the neurotrophins, Phil. Trans. R. Soc. London Ser. B: Biol. Sci. 351 (1996) 417-422.
2. [2] A. Acheson, J.C. Conover, J.P. Fandl, T.M. DeChiara, M. Russell, A. Thadani, S.P. Squinto, G.D. Yancopoulos, R.M. Lindsay, A BDNF autocrine loop in adult sensory neurons prevents cell death, Nature 374 (1995) 450-453.
3. [3] A. Adem, S.S. Jossan, R. d'Argy, P.G. Gillberg, A. Nordberg, B. Winblad, V. Sara, Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization, Brain Res. 503 (1989) 299-303.
4. [4] F. Aguado, T. Fernandez, R. Martinez-Murillo, J. Rodrigo, L. Cacicedo, F. Sanchez-Franco, Immunohistochemical localization of insulin-like growth factor I in the hypothalamo-hypophyseal system of the adult rat, Neuroendocrinology 56 (1992) 856-863.
5. [5] F. Aguado, F. Sanchez-Franco, L. Cacidedo, T. Fernandez, J. Rodrigo, R. Martinez-Murillo, Subcellular localisation of insulin-like growth factor I (IGF-I) in Purkinje cells of the adult rat: an immunocytochemical study, Neurosci. Lett. 135 (1992) 171-174.
6. [6] F. Aguado, F. Sanchez-Franco, J. Rodrigo, L. Cacicedo, R. Martinez-Murillo, Insulin-like growth factor 1-immunoreactive peptide in adult human cerebellar Purkinje cells: co-localisation with low-affinity nerve growth factor receptor, Neuroscience 59 (1994) 641-650.
7. [7] Y. Aizenman, J. de Vellis, Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation, Brain Res. 406 (1987) 32-42.
8. [8] Y. Akaneya, M. Takahashi, H. Hatanaka, Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor, Brain Res. 704 (1995) 175-183.
9. [9] R.F. Alderson, A.L. Alterman, Y. Barde, R.M. Lindsay, Brain-derived neurotrophic factor increases survival and differentiated function of rat septal cholinergic neurons in culture, Neuron 5 (1990) 297-306.
10. [10] T. Alexi, F. Hefti, Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture, Neuroscience 55 (1993) 903-918.
11. [11] M.E. Alexianu, A.M. Mohamed, R.G. Smith, L.V. Colom, S.H. Appel, Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis, J. Neurochem. 63 (1994) 2365-2368.
12. [12] S.J. Allen, D. Dawbarn, M.G. Spillantini, M. Goedert, G.K. Wilcock, T.H. Moss, F.M. Semenenko, Distribution of β-nerve growth factor receptors in the human basal forebrain, J. Comp. Neurol. 289 (1989) 626-640.
13. [13] S.J. Allen, S.H. MacGowan, J.J.S. Treanor, R. Feeny, G.K. Wilcock, D. Dawbarn, Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus, Neurosci. Lett. 131 (1991) 135-139.
14. [14] L. Altman, Programmed cell death: the paths to suicide, Trends Neurosci. 15 (1992) 278-280.
15. [15] A.J. Anderson, B.J. Cummings, C.W. Cotman, Increased immunoreactivity for Jun-and Fos-related proteins in Alzheimer's disease: association with pathology, Exp. Neurol. 125 (1994) 286-295.
16. [16] A.J. Anderson, C.J. Pike, C.W. Cotman, Differential induction of IEGs in response to A-beta peptides in cultured neurons: association between c-Jun immunoreactivity and A-beta-mediated apoptosis, J. Neurochem. 65 (1995) 1487-1498.
17. [17] A.J. Anderson, J.H. Sum, C.W. Cotman, DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area and effect of postmortem delay, J. Neurosci. 16 (1996) 1710-1719.
18. [18] K.D. Anderson, N. Panayotatos, T.L. Corcoran, R.M. Lindsay, S.J. Wiegand, Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington's disease, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7346-7351.
19. [19] P. Anglade, S. Vyas, F. Javoy-Agid, M.T. Herrero, P.P. Michel, J. Marquez, A. Mouatt-Prigent, M. Ruberg, E.C. Hirsch, Y. Agid, Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. Histopathol. 12 (1997) 25-31.
20. [20] S.H. Appel, A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer's disease, Ann. Neurol. 10 (1981) 499-505.
21. [21] D.M. Araujo, P.A. Lapchak, B. Collier, J.-G. Chabot, R. Quirion, Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system, Brain Res. 484 (1989) 130-138.
22. [22] D.M. Araujo, J.G. Chabot, R. Quirion, Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain, Int. Rev. Neurobiol. 32 (1990) 141-173.
23. [23] T. Ardent, M.K. Bruckner, T. Krell, S. Pagliusi, L. Kruska, R. Heumann, Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury: II. Reactive expression of the nerve growth factor gene in astrocytes, Neuroscience 65 (1995) 647-659.
24. [24] T. Ardent, M.K. Bruckner, S. Pagliusi, T. Krell, Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury: I. Degeneration and plastic response of basal forebrain neurons, Neuroscience 65 (1995) 633-645.
25. [25] E. Arenas, H. Persson, Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo, Nature 367 (1994) 368-371.
26. [26] E. Arenas, M. Trupp, P. Akerud, C.F. Ibanez, GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo, Neuron 15 (1995) 1465-1473.
27. [27] C. Arias, I. Arrieta, R. Tapia, Beta-amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarised hippocampal slices, J. Neurosci. Res. 41 (1995) 561-566.
28. [28] I. Aubert, J. Poirier, S. Gauthier, R. Quirion, Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions, J. Neurosci. 14 (1994) 2476-2484.
29. [29] I. Ayer-LeLievre, L. Olson, T. Ebendal, A. Seiger, H. Persson, Expression of β-nerve growth factor gene in hippocampal neurons, Science 240 (1988) 1339-1340.
30. [30] M.A. Bach, Z. Shen-Orr, W.L. Lowe, C.T. Roberts, D. LeRoith, Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain, Mol. Brain Res. 10 (1991) 43-48.
31. [31] C. Backman, G.M. Rose, B.J. Hoffer, M.A. Henry, R.T. Bartus, P. Friden, A.-C. Granholm, Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy, J. Neurosci. 16 (1996) 5437-5442.
32. [32] C. Backman, G.M. Rose, R.T. Bartus, B.J. Hoffer, E.J. Mufson, A.C. Granholm, Carrier mediated delivery of NGF: alterations in basal forebrain neurons in aged rats revealed using antibodies against low and high affinity NGF receptors, J. Comp. Neurol. 387 (1997) 1-11.
33. [33] M. Ballarin, P. Ernfors, N. Lindefors, H. Persson, Hippocampal damage and kainic acid injection induce a rapid increase in BDNF and NGF mRNA in the rat brain, Exp. Neurol. 114 (1991) 35-43.
34. [34] M. Barbacid, F. Lamballe, D. Pulido, R. Klein, The trk family of tyrosine protein kinase receptors, Biochim. Biophys. Acta 1072 (1991) 115-127.
35. [35] P.A. Barker, R.A. Murphy, The nerve growth factor receptor: a multicomponent system that mediates the actions of the neurotrophin family of proteins, Mol. Cell. Biochem. 110 (1992) 1-15.
36. [36] R.T. Bartus, R.L. Dean, S. Abelleira, V. Charles, J.H. Kordower, Dissociation of p75 receptors and nerve growth factor neurotrophic effects - lack of p75 immunoreactivity in striatum following physical trauma, excitotoxicity and NGF administration, Restor. Neurol. Neurosci. 10 (1996) 49-59.
37. [37] D.G. Baskin, B.J. Wilcox, D.P. Figlewicz, D.M. Dorsa, Insulin and insulin-like growth factors in the CNS, Trends Neurosci. 11 (1988) 107-111.
38. [38] P.E. Batchelor, D.M. Armstrong, S.N. Blaker, F.H. Gage, Nerve growth factor receptor and choline acetyltransferase colocalisation in neurons within the rat forebrain: response to fimbria-fornix transection, J. Comp. Neurol. 284 (1989) 187-204.
39. [39] A. Batistatou, L.A. Greene, Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity, J. Cell Biol. 115 (1991) 461-471.
40. [40] B.C. Baxter, Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex, J. Clin. Endocrinol. Metab. 67 (1988) 265-270.
41. [41] K.D. Beck, F. Lamballe, R. Klein, M. Barbacid, P.E. Schauwecker, T.H. McNeill, C.E. Finch, F. Hefti, J.R. Day, Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus, J. Neurosci. 13 (1993) 4001-4014.
42. [42] K.D. Beck, J. Valverde, T. Alexi, K. Poulsen, B. Moffat, R.A. Vandlen, A. Rosenthal, F. Hefti, Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain, Nature 373 (1995) 339-341.
43. [43] C. Behl, J.B. Davis, F.G. Klier, D. Schubert, Amyloid β peptide induces necrosis rather than apoptosis, Brain Res. 645 (1994) 253-264.
44. [44] E.J. Beilharz, N.D. Klempt, M. Klempt, E. Sirimanne, M. Dragunow, P.D. Gluckman, Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury, Mol. Brain Res. 18 (1993) 209-215.
45. [45] S. Bektesh, D.H. Doherty, B. Weaver, B.R. Rosenzweig, D. Pratt, F. Collins, Cloning rat and human GDNF: a distant member of the TGF-β superfamily active on midbrain dopaminergic neurons, Soc. Neurosci. Abstr. 19 (1993) 651.
46. [46] M.D.P. Berzaghi, J. Cooper, E. Castren, F. Zafra, M. Sofroniew, H. Thoenen, D. Lindholm, Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus, J. Neurosci. 13 (1993) 3818-3826.
47. [47] A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.J. Robert, J. Mallet, P. Horellou, Intrastriatal injection of an adenoviral vector expressing glial cell line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioural impairment in a rat model of Parkinson's disease, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8818-8823.
48. [48] E. Birecree, W.O. Whetsell, C. Stoscheck, L.E. King, L.B. Nanney, Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease, J. Neuropathol. Exp. Neurobiol. 47 (1988) 549-560.
49. [49] A. Bjorklund, C. Rosenblad, C. Winkler, D. Kirik, Studies of neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease, Neurobiol. Dis. 4 (1997) 186-200.
50. [50] J.P. Blass, L. Ko, H.M. Wisniewski, Pathology of Alzheimer's disease, Psychiatr. Clin. North Am. 14 (1991) 397-416.
51. [51] U. Blomer, L. Naldini, I.M. Verma, D. Trono, F.H. Gage, Application of gene therapy to the CNS, Hum. Mol. Genet. 5 (1996) 1397-1404.
52. [52] D. Blum, Y. Wu, M.F. Nissou, S. Arnaud, A. Louis-Benabid, J.M. Verna, p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells, Brain Res. 751 (1997) 139-142.
53. [53] N.J. Bohannon, E.S. Corp, B.J. Wilcox, D.P. Figlewicz, D.M. Dorsa, D.G. Baskin, Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography, Brain Res. 444 (1988) 205-213.
54. [54] M.C. Bohn, D.L. Choi-Lundberg, Gene therapies for Parkinson's disease, Gene Therapy for Neurological Disorders and Brain Tumors, Humana Press, Totowa, NJ, 1997, pp. 377-395.
55. [55] L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, C.B. Thompson, bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death, Cell 74 (1993) 597-608.
56. [56] C. Bondy, Transient IGF-I gene expression during maturation of functionally related central projection neurons, J. Neurosci. 11 (1991) 3442-3455.
57. [57] C. Bondy, H. Werner, C.T. Roberts, D. LeRoith, Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II, Neuroscience 46 (1992) 909-923.
58. [58] K.E. Bowenkamp, A.F. Hoffman, G.A. Gerhardt, M.A. Henry, P.T. Biddle, B.J. Hoffer, A.-C.E. Granholm, Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons, J. Comp. Neurol. 355 (1995) 479-489.
59. [59] W.J. Bowers, D.F. Howard, H.J. Federoff, Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease, Exp. Neurol. 144 (1997) 58-68.
60. [60] R. Brachmann, P.B. Lindquist, M. Nagashima, W. Kohr, T. Lipari, M. Napier, R. Derynck, Transmembrane TGFα precursors activate EGF/TGFα receptors, Cell 56 (1989) 691-700.
61. [61] D.E. Bredesen, M. Wiedau-Pazos, J.J. Goto, S. Rabizadeh, J.A. Roe, E.B. Gralla, L.M. Ellerby, J.S. Valentine, Cell death mechanisms in ALS, Neurology 47 (1996) S36-38.
62. [62] A.L. Brown, L. Chiariotti, C.C. Orlowski, T. Mehlman, W.H. Burgess, E.J. Ackerman, C.B. Bruni, M.M. Rechler, Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factor, J. Biol. Chem. 264 (1989) 5148-5154.
63. [63] G. Bruce, G. Heinrich, Production and characterisation of biologically active recombinant human nerve growth factor, Neurobiol. Aging 10 (1989) 89-94.
64. [64] L.I. Bruijn, D.W. Cleveland, Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease, Neuropathol. Appl. Neurobiol. 22 (1996) 373-387.
65. [65] E.W. Bruyn, T.A. Bots, R. Dom, Huntington's chorea: current neuropathological status, Adv. Neurol. 23 (1979) 83-93.
66. [66] A.W. Burgess, Epidermal growth factor and transforming growth factor α, Br. Med. Bull. 45 (1989) 401-424.
67. [67] S.K. Burgess, S. Jacobs, P. Cuatrecasa, N. Sahyoun, Characterization of a neuronal subtype of a insulin-like growth factor I receptor, J. Biol. Chem. 262 (1987) 1618-1622.
68. [68] I. Burgos, A.C. Cuello, P. Liberini, E. Pioro, E. Masliah, NGF-mediated synaptic sprouting in the cerebral cortex of lesioned primate brain, Brain Res. 692 (1995) 154-160.
69. [69] M.A. Burke, W.C. Mobley, J. Cho, S.J. Wiegand, R.M. Lindsay, E.J. Mufson, J.H. Kordower, Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins, Exp. Neurol. 130 (1994) 178-195.
70. [70] L.L. Butcher, N.J. Woolf, Neurotrophic agents may exacerbate the pathological cascade of Alzheimer's disease, Neurobiol. Aging 10 (1989) 557-570.
71. [71] M.J. Carson, R.R. Behringer, R.L. Brinster, F.A. McMorris, Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice, Neuron 10 (1993) 729-740.
72. [72] L. Cavicchioli, T.P. Flanigan, G. Vantini, M. Fusco, P. Polato, G. Toffano, F.S. Walsh, A. Leon, NGF amplifies expression of NGF receptor messenger RNA in forebrain cholinergic neurons of rats, Eur. J. Neurosci. 1 (1989) 258-261.
73. [73] M.V. Chao, B.L. Hempstead, p75 and Trk: a two-receptor system, Trends Neurosci. 18 (1995) 321-326.
74. [74] V. Charles, E.J. Mufson, P.M. Friden, R.T. Bartus, J.H. Kordower, Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate, Brain Res. 728 (1996) 193-203.
75. [75] K.S. Chen, M.H. Tuszynski, F.H. Gage, Role of neurotrophic factors in Alzheimer's disease, Neurobiol. Aging 10 (1989) 545-546.
76. [76] S.-Y. Chen, J.W. Harding, C.D. Barnes, Neuropathology of synthetic beta-amyloid peptide analogs in vivo, Brain Res. 715 (1996) 44-50.
77. [77] B. Cheng, M.P. Mattson, IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage, J. Neurosci. 12 (1992) 1558-1566.
78. [78] D.L. Choi-Lundberg, Q. Lin, Y.-N. Chang, Y.L. Chiang, C.M. Hay, H. Mohajeri, B.L. Davidson, M.C. Bohn, Dopaminergic neurons protected from degeneration by GDNF gene therapy, Science 275 (1997) 838-841.
79. [79] E.D. Clarkson, W.M. Zawada, C.R. Freed, GDNF reduces apoptosis in dopaminergic neurons in vitro, NeuroReport 7 (1995) 145-149.
80. [80] E.D. Clarkson, W.M. Zawada, C.R. Freed, GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro, Cell Tissue Res. 289 (1997) 207-210.
81. [81] D. Collerton, Cholinergic function and intellectual decline in Alzheimer's disease, Neuroscience 19 (1986) 1-28.
82. [82] J.M. Conner, S. Varon, Maintenance of sympathetic innervation into the hippocampal formation requires a continuous local availability of nerve growth factor, Neuroscience 72 (1996) 933-945.
83. [83] J.M. Conner, B. Fass-Holmes, S. Varon, Changes in nerve growth factor immunoreactivity following entorhinal cortex lesions: possible molecular mechanism regulating cholinergic sprouting, J. Comp. Neurol. 345 (1994) 409-418.
84. [84] B. Connor, D. Young, P. Lawlor, W. Gai, H. Waldvogel, R.L.M. Faull, M. Dragunow, Trk receptor alterations in Alzheimer's disease, Mol. Brain Res. 42 (1996) 1-17.
85. [85] B. Connor, E.J. Beilharz, C. Williams, P.D. Gluckman, R.L.M. Faull, M. Dragunow, Insulin-like growth factor (IGF-1) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus, Mol. Brain Res. 49 (1997) 283-290.
86. [86] B. Connor, D. Young, Q. Yan, R.L.M. Faull, B. Synek, M. Dragunow, Brain-derived neurotrophic factor is reduced in Alzheimer's disease, Mol. Brain Res. 49 (1997) 71-81.
87. [87] J.D. Cooper, D. Lindholm, M.V. Sofroniew, Reduced transport of [I] nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats, Neuroscience 62 (1994) 625-629.
88. [88] J.D. Cooper, J.N. Skepper, M. Da Penha Berzaghi, D. Lindholm, M.V. Sofroniew, Delayed death of septal cholinergic neurons after excitotoxic ablation of hippocampal neurons during early postnatal development in the rat, Exp. Neurol. 139 (1996) 143-155.
89. [89] M.H. Cortazzo, E.S. Kassis, K.A. Sproul, N.F. Schor, Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor, J. Neurosci. 16 (1996) 3895-3899.
90. [90] C.W. Cotman, A.J. Anderson, A potential role for apoptosis in neurodegeneration and Alzheimer's disease, Mol. Neurobiol. 10 (1995) 19-45.
91. [91] J.T. Coyle, D.L. Price, M.R. DeLong, Alzheimer's disease: a disorder of cortical cholinergic innervation, Science 219 (1983) 1184-1190.
92. [92] F.T. Crews, R. McElhaney, G. Freund, W.E. Ballinger, M.K. Raizada, Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients, J. Neurochem. 58 (1992) 1205-1210.
93. [93] N. Cristina, C. Chatellard-Causse, M. Manier, C. Feuerstein, GDNF: existence of a second transcript in the brain, Mol. Brain Res. 32 (1995) 354-357.
94. [94] C. Crowley, S.D. Spencer, M.C. Nishimura, K.S. Chen, S. PittsMeek, M.P. Armanini, L.H. Ling, S.B. McMahon, D.L. Shelton, A.D. Levinson, H.S. Phillips, Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons, Cell 76 (1994) 1001-1011.
95. [95] K.A. Crutcher, S.A. Scott, S. Liang, W.V. Everson, J. Weingartner, Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease, J. Neurosci. 13 (1993) 2540-2550.
96. [96] C.A. Cuello, Trophic responses of forebrain cholinergic neurons: a discussion, Prog. Brain Res. 98 (1993) 265-277.
97. [97] R. Curtis, K.M. Adryan, J.L. Stark, J.S. Park, D.L. Compton, G. Weskamp, L.J. Huber, M.V. Chao, R. Jaenisch, K.-F. Lee, R.M. Lindsay, P.S. DiStefano, Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins, Neuron 14 (1995) 1201-1211.
98. [98] I. Date, T. Ohmoto, T. Imaoka, T. Ono, J.P. Hammang, J. Francis, C. Greco, D.F. Emerich, Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioural recovery in hemiparkinsonian rats, J. Neurosurg. 84 (1996) 1006-1012.
99. [99] J.B. Davis, Oxidative mechanisms in beta-amyloid cytotoxicity, Neurodegeneration 5 (1996) 441-444.
100. [100] G. Dechant, A. Rodriguez-Tebar, Y. Barde, Neurotrophin receptors, Prog. Neurobiol. 42 (1994) 347-352.
101. [101] J. De Keyser, N. Wilczak, A. Goossen, Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease, Neurosci. Lett. 172 (1994) 93-96.
102. [102] M. DeLacoste, C.L. White, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging 14 (1993) 1-16.
103. [103] R. Derynck, Transforming growth factor α, Cell 54 (1988) 593-595.
104. [104] R. Derynck, A.B. Roberts, M.E. Winkler, E.Y. Chen, D.V. Goeddel, Human transforming growth factor-α: precursor structure and expression in E. coli, Cell 38 (1984) 287-297.
105. [105] C. Diaz-Ruiz, R. Perez-Tomas, J. Domingo, I. Ferrer, Immunohistochemical localisation of transforming growth factor-α in the choriod plexus of rat and chicken, Neurosci. Lett. 164 (1993) 44-45.
106. [106] S.R. D'Mello, C. Galli, T. Ciotti, P. Calissano, Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10989-10993.
107. [107] S. Dore, C. Krieger, S. Kar, R. Quirion, Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cord of amyotrophic lateral sclerosis (ALS) patients, Mol. Brain Res. 41 (1996) 128-133.
108. [108] S. Dore, S. Kar, R. Quirion, Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid-and human amylin-induced toxicity, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4772-4777.
109. [109] S. Dore, S. Kar, R. Quirion, Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases, Trends Neurosci. 20 (1997) 326-331.
110. 125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats, Neuroscience 80 (1997) 1033-1040.
111. [111] B. Drache, G.E. Diehl, K. Beyreuther, L.S. Perlmutter, G. Konig, Bcl-xl-specific antibody labels activated microglia associated with Alzheimer's disease and other pathological states, J. Neurosci. Res. 47 (1997) 98-108.
112. [112] J. Drago, M. Murphy, S.M. Carroll, R.P. Harveym, P.F. Bartlett, Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2199-2203.
113. [113] J. Drago, T.J. Kilpatrick, S.A. Koblar, P.S. Talman, Growth factors: potential therapeutic applications in neurology, J. Neurol. Neurosurg. Psychiatry 57 (1994) 1445-1450.
114. [114] M. Dragunow, K. Preston, The role of inducible transcription factors in apoptotic nerve cell death, Brain Res. Rev. 21 (1995) 1-28.
115. [115] M. Dragunow, E. Beilharz, B. Mason, P. Lawlor, W. Abraham, P. Gluckman, Brain-derived neurotrophic factor expression after long-term potentiation, Neurosci. Lett. 160 (1993) 232-236.
116. [116] M. Dragunow, D. Young, P. Hughes, G. MacGibbon, P. Lawlor, K. Singleton, E. Sirimanne, E. Beilharz, P. Gluckman, Is c-Jun involved in nerve cell death following status epilepticus and hypoxia-ischemic brain injury?, Mol. Brain Res. 18 (1993) 347-352.
117. [117] M. Dragunow, E. Beilharz, E. Sirimanne, P. Lawlor, C. Williams, R. Bravo, P. Gluckman, Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to young rat brain, Mol. Brain Res. 25 (1994) 19-33.
118. [118] M. Dragunow, R.L.M. Faull, P. Lawlor, E.J. Beilharz, K. Singleton, E.B. Walker, E. Mee, In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, NeuroReport 6 (1995) 1053-1057.
119. [119] M.M. Dugich-Djordjevic, C. Peterson, F. Isono, H.R. Widmer, T.L. Denton, G.L. Bennett, F. Hefti, Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain, Eur. J. Neurosci. 7 (1995) 1831-1839.
120. [120] P. Durbec, C.V. Marcos-Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, H. Sariola, V. Pachnis, GDNF signalling through the Ret receptor tyrosine kinase, Nature 381 (1996) 789-792.
121. [121] L.S. Dure, S. Wiess, D.G. Standaert, G. Rudolf, C.M. Testa, A.B. Young, DNA fragmentation and immediate early gene expression in rat striatum following quinolinic acid administration, Exp. Neurol. 133 (1995) 207-214.
122. [122] H.D. Durham, J. Roy, L. Dong, D.A. Figlewicz, Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS, J. Neuropathol. Exp. Neurol. 56 (1997) 523-530.
123. [123] P. Dutar, B. Potier, Y. Lamour, P.C. Emson, M.C. Semut, Loss of calbindin-28K immunoreactivity in hippocampal slices from aged rats: a role for calcium?, Eur. J. Neurosci. 3 (1991) 839-849.
124. [124] H.M. Duvernoy, The Human Hippocampus: An Atlas of Applied Anatomy, J.F. Bergmann Verlag Munchen (Eds.), Munchen, 1988.
125. [125] F.F. Eide, E.R. Vining, B.L. Eide, K. Zang, X.-Y. Wang, L.F. Reichardt, Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signalling, J. Neurosci. 16 (1996) 3121-3129.
126. [126] A. Eisen, C. Krieger, Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis, Can. J. Neurol. Sci. 20 (1993) 286-296.
127. [127] R.G. Elgin, W.H. Busby, D.R. Clemmons, An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I, Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3254-3258.
128. [128] D.F. Emerich, S.R. Winn, J. Harper, J.P. Hammang, E.E. Baetge, J.H. Kordower, Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons, J. Comp. Neurol. 349 (1994) 148-164.
129. [129] D.F. Emerich, M.D. Lindner, S.R. Winn, E.-Y. Chen, B.R. Frydel, J.H. Kordower, Implants of encapsulated human CNTF-producing fibroblasts prevent behavioural deficits and striatal degeneration in a rodent model of Huntington's disease, J. Neurosci. 16 (1996) 5168-5181.
130. [130] D.F. Emerich, M. Plone, J. Francis, B.R. Frydel, S.R. Winn, M.D. Lindner, Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts, Brain Res. 736 (1996) 99-110.
131. [131] D.F. Emerich, C.K. Cain, C. Greco, J.A. Saydoff, Z.Y. Hu, H. Liu, M.D. Lindner, Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease, Cell Transplant. 6 (1997) 249-266.
132. [132] D.F. Emerich, S.R. Winn, P.M. Hantraye, M. Peschanski, E.-Y. Chen, Y. Chu, P. McDermott, E.E. Baetge, J.H. Kordower, Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease, Nature 386 (1997) 395-398.
133. [133] C.J. Emmett, S.P. Aswani, G.R. Stewart, D. Fairchild, R.M. Johnson, Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration, Brain Res. 673 (1995) 199-207.
134. [134] J. Engele, H. Rieck, M.C. Bohn, Identification of a glial-derived neurotrophic factor for mesencephalic dopaminergic neurons, Soc. Neurosci. Abstr. 19 (1993) 652.
135. [135] P. Ernfors, C.F. Ibanez, T. Ebendal, L. Olson, H. Persson, Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 5454-5458.
136. [136] S. Estus, W.J. Zaks, R.S. Freeman, M. Gruda, R. Bravo, E.M. Johnson, Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis, J. Cell Biol. 127 (1994) 1717-1727.
137. [137] A.B.-V. Evercooren, C. Olichon-Berthe, A. Kowalski, G. Visciano, E. Van Obberghen, Expression of IGF-I and insulin receptor genes in the rat central nervous system: a development, regional and cellular analysis, J. Neurosci. Res. 28 (1991) 244-253.
138. [138] A.M. Fagan, F.H. Gage, Cholinergic sprouting in the hippocampus: a proposal for IL-1, Exp. Neurol. 110 (1990) 105-120.
139. [139] T. Falkenberg, P. Ernfors, H. Persson, N. Lindfors, Cortical transynaptic activation of tyrosine kinase receptor TrkB messenger RNA expression in rat hippocampus, Neuroscience 51 (1992) 883-889.
140. [140] T. Falkenberg, M. Metsis, T. Timmusk, N. Lindefors, Entorhinal cortex regulation of multiple brain-derived neurotrophic factor promoters in the rat hippocampus, Neuroscience 57 (1993) 891-896.
141. [141] J.H. Fallon, C.M. Annis, L.E. Gentry, D.R. Twardzik, S.E. Loughlin, Localisation of cells containing transforming growth factor-α precursor immunoreactivity in the basal ganglia of the adult rat brain, Growth Factors 2 (1990) 241-250.
142. [142] I. Farinas, K.R. Jones, C. Backus, X.Y. Wang, L.F. Reichardt, Severe sensory and sympathetic deficits in mice lacking neurotrophin-3, Nature 369 (1994) 658-661.
143. [143] T.W. Farris, L.L. Butcher, J.D. Oh, N.J. Wolf, Trophic-factor modulation of cortical acetylcholinesterase reappearance following transection of the medial cholinergic pathway in the adult rat, Exp. Neurol. 131 (1995) 180-192.
144. [144] I. Ferrer, R. Blanco, M. Carulla, M. Condom, S. Alcantara, M. Olive, A. Planas, Transforming growth factor-α immunoreactivity in the developing and adult brain, Neuroscience 66 (1995) 189-199.
145. [145] W. Fischer, K. Wictorin, A. Bjorklund, L.R. Wiliams, S. Varon, F.H. Gage, Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor, Nature 329 (1987) 65-68.
146. [146] W. Fischer, A. Sirevaag, S.J. Wiegand, R.M. Lindsay, A. Bjorklund, Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophin 3 and 4/5 but not brain-derived neurotrophic factor, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8607-8611.
147. [147] G. Forloni, R. Chiesa, S. Smiroldo, L. Verga, M. Salmona, F. Tagliavini, N. Angeretti, Apoptosis mediated neurotoxicity induced by chronic application of beta-amyloid fragment 25-35, NeuroReport 4 (1993) 523-526.
148. [148] L.S. Forno, Neuropathology of Parkinson's disease, J. Neuropathol. Exp. Neurol. 55 (1996) 259-272.
149. [149] P.T. Francis, N.R. Sims, A.W. Procter, D.M. Bowen, Cortical pyramidal neuron loss may cause glutaminergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives, J. Neurochem. 5 (1993) 1589-1601.
150. [150] U. Francke, B. DeMartinville, L. Coussens, A. Ullrich, The human gene for the beta-subunit of nerve growth factor is located on the proximal short arm of chromosome 1, Science 222 (1983) 1248-1250.
151. [151] A. Fraser, N. McCarthy, G.I. Evan, Biochemistry of cell death, Curr. Opin. Neurobiol. 6 (1996) 71-80.
152. [152] A. Freese, M. Stern, M.G. Kaplitt, W.M. O'Connor, M.V. Abbey, M.J. O'Connor, M.J. During, Prospects for gene therapy in Parkinson's disease, Mov. Disord. 11 (1996) 469-488.
153. [153] P.M. Friden, L.R. Walus, P. Watson, S.R. Doctrow, J.W. Kozarich, C. Backman, H. Bergman, B. Hoffer, F. Bloom, A. Granholm, Blood-brain penetration and in vivo activity of an NGF conjugate, Science 259 (1993) 373-376.
154. [154] W.J. Friedman, C.F. Ibanez, F. Hallbrook, H. Persson, L.D. Cain, C.F. Dreyfus, I.E. Black, Differential actions of neurotrophins in the locus coeruleus and basal forebrain, Exp. Neurol. 119 (1993) 72-78.
155. [155] W.J. Friedman, I.B. Black, H. Persson, C.F. Ibanez, Synergistic trophic actions on rat basal forebrain neurons revealed by a synthetic NGF/BDNF chimaeric molecule, Eur. J. Neurosci. 7 (1995) 656-662.
156. [156] D.M. Frim, M.P. Short, W.S. Rosenberg, J. Simpson, X.O. Breakefield, O. Isacson, Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum, J. Neurosurg. 78 (1993) 267-273.
157. [157] D.M. Frim, J. Simpson, T.A. Uhler, M.P. Short, S.R. Bossi, X.O. Breakefield, O. Isacson, Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF, J. Neurosci. Res. 35 (1993) 452-458.
158. [158] M. Frotscher, P. Kugler, U. Misgeld, K. Zilles, Advances in Anatomy, Embryology and Cell Biology, Springer, Berlin, 1988.
159. [159] F.H. Gage, D.M. Armstrong, L.R. Williams, S. Varon, Morphological response of axotomised septal neurons to nerve growth factor, J. Comp. Neurol. 269 (1988) 147-155.
160. [160] C.M. Gall, Regulation of brain neurotrophin expression by physiological activity, Trends Pharmacol. 13 (1992) 401-403.
161. [161] C.M. Gall, S.J. Gold, P.J. Isackson, K.B. Seroogy, Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons, Mol. Cell. Neurosci. 3 (1992) 56-63.
162. [162] C. Galli, O. Meucci, A. Scorziello, T.M. Werge, P. Calissano, G. Schettini, Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis, J. Neurosci. 15 (1995) 1172-1179.
163. [163] W.R. Galpern, D.M. Frim, S.B. Tatter, C.A. Altar, M.F. Beal, O. Isacson, Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration, Cell Transplant. 5 (1996) 225-232.
164. [164] S. Gammeltoft, G.K. Haselbacher, R.E. Humbel, M. Fehlmann, E. Van Obberghen, Two types of receptor for insulin-like growth factors in mammalian brain, EMBO J. 4 (1985) 3407-3412.
165. [165] J. Garcia-Estrada, L.M. Garcia-Segura, I. Torres-Aleman, Expression of insulin-like growth factor 1 by astrocytes in response to injury, Brain Res. 592 (1992) 343-347.
166. [166] L.M. Garcia-Segura, J. Perez, S. Pons, M.T. Rejas, I. Torres-Aleman, Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain, Brain Res. 560 (1991) 167-174.
167. [167] D.M. Gash, Z. Zhang, W.A. Cass, A. Ovadia, L. Simmerman, D. Martin, D. Russell, F. Collins, B.J. Hoffer, G.A. Gerhardt, Morphological and functional effects of intranigrally administered GDNF in normal Rhesus monkeys, J. Comp. Neurol. 363 (1995) 345-358.
168. [168] D.M. Gash, Z. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer, G.A. Gerhardt, Functional recovery in Parkinsonian monkeys treated with GDNF, Nature 380 (1996) 252-255.
169. [169] U.E. Gasser, G. Weskamp, U. Otten, A.R. Dravid, Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septohippocampal pathway in rats, Brain 376 (1986) 351-356.
170. [170] L.E. Gentry, D.R. Twardzik, G.J. Lim, J.E. Ranchalis, D.C. Lee, Expression and characterisation of transforming growth factor α precursor protein in transfected mammalian cells, Mol. Cell. Biol. 7 (1987) 1585-1591.
171. [171] A. Ghosh, J. Carnahan, M.E. Greenberg, Requirement of BDNF in activity-dependent survival of cortical neurons, Science 263 (1994) 1618-1623.
172. [172] R.B. Gibbs, M.V. Chao, D.W. Pfaff, Effects of fimbria-fornix and angular bundle transection on expression of the p75 mRNA by cells in the medial septum and diagonal band of Broca: correlations with cell survival, synaptic reorganisation and sprouting, Mol. Brain Res. 11 (1991) 207-219.
173. [173] F. Gillardon, L. Klimaschewski, H. Wickert, S. Krajewski, J.C. Reed, M. Zimmermann, Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-X and c-Jun in sensory and motor neurons following sciatic nerve transection in the rat, Brain Res. 739 (1996) 244-250.
174. [174] M. Gimenez y Ribotta, F. Revah, L. Pradier, I. Loquet, J. Mallet, A. Privat, Prevention of motoneuron death by adenovirus-mediated neurotrophic factors, J. Neurosci. Res. 48 (1997) 281-285.
175. [175] P.D. Gluckman, J. Guan, E.J. Beilharz, N.D. Klempt, M. Klempt, O. Miller, E. Sirimanne, M. Dragunow, C.E. Williams, The role of insulin-like growth factor system in neuronal rescue, Ann. NY Acad. Sci. 692 (1993) 138-148.
176. [176] M. Goedert, Tau protein and the neurofibrillary pathology of Alzheimer's disease, Trends Neurosci. 16 (1993) 460-465.
177. [177] M. Goedert, A. Fine, S.P. Hunt, A. Ullrich, Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease, Mol. Brain Res. 1 (1986) 85-92.
178. [178] M. Granerus, P. Schofield, P. Bierke, W. Engstrom, Growth factors and apoptosis in development - the role of insulin-like growth factor I and TGF-beta-1 in regulating cell growth and cell death in a human teratocarcinoma-derived cell line, Int. J. Dev. Biol. 39 (1995) 759-764.
179. [179] J. Guan, C.E. Williams, M. Gunning, E.C. Mallard, P.D. Gluckman, The effects of IGF-I treatment after hypoxic-ischemic injury in adult rats, J. Cereb. Blood Flow Metab. 13 (1993) 609-616.
180. [180] J.F. Gusella, M.E. MacDonald, Huntington's disease, Semin. Cell Biol. 6 (1995) 21-28.
181. [181] G. Haase, P. Kennel, B. Pettmann, E. Vigne, S. Akli, F. Revah, H. Schmalbruch, A. Kahn, Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors, Nat. Med. 3 (1997) 429-436.
182. [182] J. Ham, C. Babji, J. Whitfield, C.M. Pfarr, D. Lallemand, M. Yaniv, L.L. Rubin, A c-jun dominant negative mutant protects neurons against programmed cell death, Neuron 14 (1995) 927-939.
183. [183] J.E. Hamos, L.J. DeGannaro, D.A. Drachman, Synaptic loss in Alzheimer's disease and other dementias, Neurology 39 (1989) 355-361.
184. [184] V.K.M. Han, J.M. Lauder, A.J. D'Ercole, Rat astroglial somatomedin/insulin-like growth factor binding proteins: characterization and evidence of biological function, J. Neurosci. 8 (1988) 3135-3143.
185. [185] J.A. Hardy, G.A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science 256 (1992) 184-185.
186. [186] M.R. Harrigan, D.D. Kunkel, L.B. Nguyen, A.T. Malouf, Beta amyloid is neurotoxic in hippocampal slice cultures, Neurobiol. Aging 16 (1995) 779-789.
187. [187] D.S. Hartman, C. Hertel, Nerve growth factor-induced differentiation in neuroblastoma cells expressing TrkA but lacking p75 NGFR, J. Neurochem. 63 (1994) 1261-1270.
188. [188] I. Hassouna, H. Wickert, M. Zimmermann, F. Gillardon, Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice, Neurosci. Lett. 204 (1996) 85-88.
189. [189] F. Hefti, Is Alzheimer's disease caused by lack of nerve growth factor?, Ann. Neurol. 13 (1983) 109-110.
190. [190] F. Hefti, Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after injury, Proc. Soc. Neurosci. 11 (1985) 660.
191. [191] F. Hefti, Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections, J. Neurosci. 6 (1986) 2155-2162.
192. [192] F. Hefti, D.C. Mash, Localisation of nerve growth factor receptors in the normal human brain and in Alzheimer's disease, Neurobiol. Aging 10 (1989) 75-87.
193. [193] F. Hefti, W.J. Weiner, Nerve growth factor and Alzheimer's disease, Ann. Neurol. 20 (1986) 275-281.
194. [194] F. Hefti, A. Dravid, J. Hartikka, Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions, Brain Res. 293 (1984) 305-311.
195. [195] F. Hefti, J. Hartikka, A. Salvatierra, W.J. Weiner, D.C. Mash, Localisation of nerve growth factor receptors in cholinergic neurons of the human basal forebrain, Neurosci. Lett. 69 (1986) 37-41.
196. [196] F. Hefti, B. Knusel, P.A. Lapchak, Protective effects of nerve growth factor and brain-derived neurotrophic factor on basal forebrain cholinergic neurons in adult rats with partial fimbrial transections, Prog. Brain Res. 98 (1993) 257-263.
197. [197] C.-P. Heisenberg, J.D. Cooper, J. Berke, M.V. Sofroniew, NMDA potentiates NGF-induced sprouting of septal cholinergic fibres, NeuroReport 5 (1994) 413-416.
198. [198] A. Heller, S. Price, L. Won, Glial-derived neurotrophic factor (GDNF) induced morphological differentiation of an immortalized monoclonal hybrid dopaminergic cell line of mesencephalic neuronal origin, Brain Res. 725 (1996) 132-136.
199. [199] R. Hellweg, W. Fischer, C. Hock, F.H. Gage, A. Bjorklund, H. Thoenen, Nerve growth factor levels and choline acetlytransferase activity in the brain of aged rats with spatial memory impairments, Brain Res. 537 (1990) 123-130.
200. [200] B.L. Hempstead, L.S. Schleifer, M.V. Chao, Expression of functional nerve growth factor receptors after gene transfer, Science 243 (1989) 373-375.
201. [201] C.E. Henderson, Role of neurotrophic factors in neuronal development, Curr. Opin. Neurobiol. 6 (1996) 64-70.
202. [202] H.R. Herschman, Polypeptide growth factors and the CNS, Trends Neurosci. 9 (1986) 53-58.
203. [203] G.A. Higgins, E.J. Mufson, NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease, Exp. Neurol. 106 (1989) 222-236.
204. [204] A. Ho, A.C. Gore, C.S. Weickert, M. Blum, Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes, NeuroReport 6 (1995) 1454-1458.
205. [205] D.M. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber, S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature 348 (1990) 334-336.
206. [206] H.M. Hofer, Y.A. Barde, Brain-derived neurotrophic factor prevents neuronal death in vivo, Nature 331 (1988) 261-262.
207. [207] B.J. Hoffer, A. Hoffman, K. Bowenkamp, P. Huettl, J. Hudson, D. Martin, L.-F.H. Lin, G.A. Gerhardt, Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo, Neurosci. Lett. 182 (1994) 107-111.
208. [208] D. Hoffman, X.O. Breakefield, M.P. Short, P. Aebischer, Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF, Exp. Neurol. 122 (1993) 100-106.
209. [209] A. Hohn, J. Leibrock, K. Bailey, Y.-A. Barde, Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic family, Nature 344 (1990) 339-340.
210. [210] D.M. Holtzman, W.C. Mobley, Neurotrophic factors and neurologic disease, West. J. Med. 161 (1994) 246-254.
211. [211] D.M. Holtzman, Y. Li, K. Chen, F.H. Gage, C.J. Epstein, W.C. Mobley, Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration, Neurology 43 (1993) 2668-2673.
212. [212] P. Horellou, A. Bilang-Bleuel, J. Mallet, In vivo adenovirus-mediated gene transfer for Parkinson's disease, Neurobiol. Dis. 4 (1997) 280-287.
213. [213] P. Horellou, O. Sabate, M.H. Buc-Caron, J. Mallet, Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease, Exp. Neurol. 144 (1997) 131-138.
214. [214] H. Hortnagl, R. Hellweg, Pathophysiological aspects of human neurodegenerative diseases, Wien Klin Wochenschr 109 (1997) 623-635.
215. [215] J.-G.G. Hou, L.-F.H. Lin, C. Mytilineou, Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium, J. Neurochem. 66 (1996) 74-82.
216. [216] J. Hudson, A.C. Granholm, G. Gerhardt, A. Hoffman, P. Biddle, N.S. Leela, F. Collins, B. Hoffer, In vivo activity of GDNF, a glial-cell-line derived neurotrophic factor on the rat nigrostriatal dopamine system, Soc. Neurosci. Abstr. 19 (1993) 652.
217. [217] P. Hughes, E. Beilharz, P. Gluckman, M. Dragunow, Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation, Neuroscience 57 (1993) 319-328.
218. [218] C. Humpel, I. Stromberg, S. Bektesh, F. Collins, L. Olson, Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation, Neuroscience 59 (1994) 791-795.
219. [219] G.W. Huntley, D.L. Benson, E.G. Jones, P.J. Isackson, Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex, Dev. Brain Res. 70 (1992) 53-63.
220. [220] B.T. Hyman, G.W. Van Hoesen, A.R. Damasio, C.L. Barnes, Alzheimer's disease: cell-specific pathology isolates the hippocampal formation, Science 225 (1984) 1168-1169.
221. [221] B.T. Hyman, G.W. Van Hoesen, L.J. Kromer, A.R. Damasio, Perforant pathway changes and the memory impairment of Alzheimer's disease, Ann. Neurol. 20 (1986) 472-481.
222. [222] B.T. Hyman, B.A. Kromer, G.W. Van Hoesen, Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease, Ann. Neurol. 21 (1987) 259-267.
223. [223] C. Hyman, M. Hofer, Y.-A. Barde, M. Juhasz, G.D. Yancopoulos, S.P. Squinto, R.M. Lindsay, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature 350 (1991) 230-233.
224. [224] A.M. Iacopino, S. Christakos, Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegeneration diseases, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4078-4082.
225. [225] A.M. Iacopino, S. Christakos, D. German, P.K. Sonsalla, C.A. Altar, Calbindin D28K-containing neurons in animal models of neurodegeneration: possible detection from excitotoxicity, Mol. Brain Res. 13 (1992) 251-261.
226. [226] K. Ikeda, B. Klinkosz, T. Greene, J.M. Cedarbaum, V. Wong, R.M. Lindsay, H. Mitsumoto, Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease, Ann. Neurol. 37 (1995) 505-511.
227. [227] N.Y. Ip, Y. Li, G.D. Yancopoulos, R.M. Lindsay, Cultured hippocampal neurons show responses to BDNF, NT-3 and NT-4, but not NGF, J. Neurosci. 13 (1993) 3394-3405.
228. [228] N.D. James, D.R. Davis, J. Sindon, D.P. Hanger, J.-P. Brion, C.C.J. Miller, M.P. Rosenberg, B.H. Anderton, F. Propst, Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos, Neurobiol. Aging 17 (1996) 235-241.
229. [229] L.S. Janis, M.M. Glasier, G. Martin, R.W. Stackman, T.J. Walsh, D.G. Stein, A single intraseptal injection of nerve growth factor facilitates radial maze performance following damage to the medial septum in rats, Brain Res. 679 (1995) 99-109.
230. [230] P. Jenner, A.H.V. Schapira, C.D. Marsden, New insights into the cause of Parkinson's disease, Neurology 42 (1992) 2241-2250.
231. [231] F. Jerusalem, C. Pohl, J. Karitzky, F. Ries, ALS Neurol. 47 (1996) S218-S220.
232. [232] N. Jette, M.S. Cole, M. Fahnestock, NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients, Mol. Brain Res. 25 (1994) 242-250.
233. [233] S. Jing, P. Tapley, M. Barbacid, Nerve growth factor mediates signal transduction through trk homodimer receptor, Neuron 9 (1992) 1067-1079.
234. [234] S. Jing, D. Wen, Y. Yu, P.L. Hoist, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J.-C. Louis, S. Hu, B.W. Altrock, G.M. Fox, GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNF-alpha, a novel receptor for GDNF, Cell 85 (1996) 1113-1124.
235. [235] E.M. Johnson, M. Taniuchi, Nerve growth factor (NGF) receptors in the central nervous system, Biochem. Pharmacol. 36 (1987) 4189-4195.
236. [236] E.M. Johnson, J.Y. Chang, T. Koike, D.P. Martin, Why do neurons die when deprived of trophic factors?, Neurobiol. Aging 10 (1989) 549-552.
237. [237] B.M. Johnston, E.C. Mallard, C.E. Williams, P.D. Gluckman, Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs, J. Clin. Invest. 97 (1996) 300-308.
238. [238] E.O. Junard, C.N. Montero, F. Hefti, Long-term administration of mouse nerve growth factor to adult rats with parial lesions of the cholinergic septohippocampal pathway, Exp. Neurol. 110 (1990) 25-38.
239. [239] Y.K. Jung, M. Miura, J.Y. Yuan, Suppression of interleukin-1-beta-converting enzyme-mediated cell death by insulin-like growth factor, J. Biol. Chem. 271 (1996) 5112-5117.
240. [240] M.-P. Junier, M. Coulpier, N. Le Forestier, J. Cadusseau, F. Suzuki, M. Peschanski, P.A. Dreyfus, Transforming growth factor α (TGFα) expression in degenerating motoneurons of the murine mutant wobbler: a neuronal signal for astrogliosis?, J. Neurosci. 14 (1994) 4206-4216.
241. [241] E.C. Kaal, E.A. Joosten, P.R. Bar, Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract, Neurochem. Int. 31 (1997) 193-201.
242. [242] D.J. Kane, T. Ord, R. Anton, D.E. Bredesen, Expression of bcl-2 inhibits necrotic cell death, J. Neurosci. Res. 40 (1995) 269-275.
243. [243] H. Kang, E.M. Schuman, Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus, Science 267 (1995) 1658-1662.
244. [244] D.R. Kaplan, B.L. Hempstead, D. Martin-Zanca, M.V. Chao, L.F. Parada, The trk proto-oncogene product: a signal transducing receptor for nerve growth factor, Science 252 (1991) 554-557.
245. 125I]insulin receptor binding sites in the rat hippocampal formation, Neuroscience 55 (1993) 69-80.
246. [246] G. Karpitti, H. Lochmuller, J. Nalbantoglu, H. Durham, The principles of gene therapy for the nervous system, Trends Neurosci. 19 (1996) 49-54.
247. [247] M.R. Kaser, J. Lakshmana, D.A. Fisher, Comparison between epidermal growth factor, transforming growth factor-α and EGF receptor levels in regions of adult rat brain, Mol. Brain Res. 16 (1992) 316-322.
248. [248] J. Kerwin, C. Morris, A. Oakley, R. Perry, E. Perry, Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus, Neurosci. Lett. 121 (1990) 178-182.
249. [249] J.M. Kerwin, C.M. Morris, R.H. Perry, E.K. Perry, Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease, Neurosci. Lett. 143 (1992) 101-104.
250. [250] P.B. Kirschner, B.G. Jenkins, J.B. Schulz, S.P. Finkelstein, R.T. Matthews, B.R. Rosen, M.F. Beal, NGF, BDNF and NT-5 but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals, Brain Res. 713 (1996) 178-185.
251. [251] R. Klein, D. Conway, L.F. Parada, M. Barbacid, The trkB tyrosine protein kinase receptor gene codes for a second neurogenic receptor that lacks the catalytic kinase domain, Cell 61 (1990) 647-656.
252. [252] R. Klein, S. Jing, V. Nanduri, E. O'Rourke, M. Barbacid, The trk proto-oncogene encodes a receptor for nerve growth factor, Cell 65 (1991) 189-197.
253. [253] R. Klein, V. Nanduri, S. Jing, F. Lambelle, P. Tapley, S. Bryant, C. Cordon-Cardo, K.R. Jones, L.F. Reichardt, M. Barbacid, The TrkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3, Cell 66 (1991) 395-403.
254. [254] R. Klein, R.J. Smeyne, W. Wurst, L.K. Long, B.A. Auerbach, A.L. Joyner, M. Barbacid, Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death, Cell 75 (1993) 113-122.
255. [255] N.D. Klempt, M. Klempt, A.J. Gunn, K. Singh, P.D. Gluckman, Expression of insulin-like growth factor-binding protein 2 (IGF-BP2) following transient hypoxia-ischemia in the infant rat brain, Mol. Brain Res. 15 (1992) 55-61.
256. [256] M. Knipper, M.D.P. Berzagh, A. Blochl, H. Breer, H. Thoenen, D. Lindholm, Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus, Eur. J. Neurosci. 6 (1994) 668-671.
257. [257] M. Knipper, M. da Penha Berzaghi, A. Blochl, H. Breer, H. Thoenen, D. Lindholm, Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus, Eur. J. Neurosci. 6 (1994) 668-671.
258. [258] B. Knusel, P.P. Michel, J.S. Schwaber, F. Hefti, Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II, J. Neurosci. 10 (1990) 558-570.
259. [259] B. Knusel, K.D. Beck, J.W. Winslow, A. Rosenthal, L.E. Burton, H.R. Widmer, K. Nikolics, F. Hefti, Brain-derived neurotrophic factor administration protects basal brain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain, J. Neurosci. 12 (1992) 4391-4402.
260. [260] S. Koh, G.A. Oyler, G.A. Higgins, Localisation of nerve growth factor receptor messenger RNA and protein in the adult rat brain, Exp. Neurol. 106 (1989) 209-221.
261. [261] Z. Kokaia, J. Bengzon, M. Metsis, M. Kokaia, H. Persson, O. Lindvall, Coexpression of neurotrophins and their receptors in neurons of the central nervous system, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6711-6715.
262. [262] Z. Kokaia, M. Metsis, M. Kokaia, J. Bengzon, E. Elmer, M.-L. Smith, T. Timmusk, B.K. Siesjo, H. Persson, O. Lindvall, Brain insults in rats induce increased expression of the BDNF gene through differential use of multiple promoters, Eur. J. Neurosci. 6 (1993) 587-596.
263. [263] V.E. Koliatsos, M.D. Applegate, B. Knusel, E.O. Junard, L.E. Burton, W.C. Mobley, F. Hefti, D. Price, Recombinant human nerve growth factor prevents retrograde degeneration of axotomised basal forebrain cholinergic neurons in the rat, Exp. Neurol. 112 (1991) 161-173.
264. [264] V.E. Koliatsos, R.E. Clatterbuck, H.J.W. Nauta, B. Knusel, L.E. Burton, F.F. Hefti, W.C. Mobley, D.L. Price, Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates, Ann. Neurol. 30 (1991) 831-840.
265. [265] V.E. Koliatsos, D.L. Price, G.K. Gouras, M.H. Cayouette, L.E. Burton, J.W. Winslow, Highly selective effects of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons, J. Comp. Neurol. 343 (1994) 247-262.
266. [266] J.H. Kordower, D.M. Gash, M. Bothwell, L. Hersh, E.J. Mufson, Nerve growth factor receptor and choline acetyltransferase remain colocalised in the nucleus basalis (Ch4) of Alzheimer's patients, Neurobiol. Aging 10 (1989) 67-74.
267. [267] J.H. Kordower, V. Charles, R. Bayer, R.T. Bartus, S. Putney, L.R. Walus, P.M. Friden, Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in the model of Huntington disease, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9077-9080.
268. [268] J.H. Kordower, E. Chen, J.R. Sladek, E.J. Mufson, TRK-immunoreactivity in the monkey central nervous system: forebrain, J. Comp. Neurol. 349 (1994) 20-35.
269. [269] J.H. Kordower, S.R. Winn, Y. Liu, E.J. Mufson, J.R. Sladek, J.P. Hammang, E.E. Baetge, D.F. Emerich, The aged monkey basal forebrain: rescue and sprouting of axotomised basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10898-10902.
270. [270] J.H. Kordower, E.Y. Chen, E.J. Mufson, S.R. Winn, D.F. Emerich, Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons, Neuroscience 72 (1996) 63-77.
271. [271] J.H. Kordower, E.J. Mufson, N. Fox, L. Martel, D.F. Emerich, Cellular delivery of NGF does not alter the expression of beta-amyloid immunoreactivity in young or aged nonhuman primates, Exp. Neurol. 145 (1997) 586-591.
272. [272] S. Korsching, G. Auburger, R. Heumann, J. Scott, H. Thoenen, Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation, EMBO J. 4 (1985) 1389-1393.
273. [273] S.J. Korsmeyer, J.R. Shutter, D.J. Veis, D.E. Merry, Z.N. Oltvai, Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death, Semin. Cancer Biol. 4 (1993) 327-332.
274. [274] S. Kosel, R. Egensperger, U. von Eitzen, P. Mehraein, M.B. Graeber, On the question of apoptosis in the Parkinsonian substantia nigra, Acta Neuropathol. 93 (1997) 105-108.
275. [275] K.S. Kosik, Alzheimer plaques and tangles: advances on both fronts, Trends Neurosci. 14 (1991) 218-219.
276. [276] K. Krieglstein, C. Suter-Crazzolara, K. Unsicker, TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity, EMBO J. 14 (1995) 736-742.
277. [277] J.E. Kudlow, A.W.C. Leung, M.S. Kobrin, A.J. Paterson, S.L. Asa, Transforming growth factor-α in the mammalian brain, J. Biol. Chem. 264 (1989) 3880-3883.
278. [278] A. Kupsch, W.H. Oertel, C.D. Earl, J. Sautter, Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease - update February 1995, J. Neural Transm. Suppl. 46 (1995) 193-207.
279. [279] P.A. Lapchack, Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease, Exp. Neurol. 124 (1993) 16-20.
280. 3H]acetylcholine release and choline acetyltransferase activity, Neuroscience 42 (1991) 639-649.
281. [281] P.A. Lapchak, D.M. Araujo, F. Hefti, BDNF and trkB mRNA expression in the rat hippocampus following entorhinal cortex lesions, NeuroReport 4 (1993) 191-194.
282. [282] H. Lassmann, C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger, H.M. Wisniewski, Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ, Acta Neuropathol. 89 (1995) 35-41.
283. [283] L.M. Lazar, M. Blum, Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-α mRNA in mouse brain by quantitative nuclease protection assay, J. Neurosci. 12 (1992) 1688-1697.
284. [284] W.-H. Lee, S. Javedan, C.A. Bondy, Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development, J. Neurosci. 12 (1992) 4737-4744.
285. [285] D. LeRoith, H. Werner, T.N. Faria, H. Kato, M. Adamo, C.T. Roberts, Insulin-like growth factor receptor: implications for nervous system function, Ann. NY Acad. Sci. 692 (1993) 22-32.
286. [286] M.A. Lesniak, J.M. Hill, W. Kiess, M. Rojeski, C.B. Pert, J. Roth, Receptors for insulin-like growth factor I and II: autoradiographic localization in rat brain and comparison to receptors for insulin, Endocrinology 123 (1988) 2089-2099.
287. [287] R. Levi-Montalcini, The nerve growth factor: thirty-five years later, EMBO J. 6 (1987) 1145-1154.
288. [288] M. Levivier, S. Przedborski, C. Bencsics, U.J. Kang, Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease, J. Neurosci. 15 (1995) 7810-7820.
289. [289] C.A.-L. Lievre, P.-A. Stahlbom, V.R. Sara, Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus, Development 111 (1991) 105-115.
290. [290] J.D. Lile, T.J. Zhang, D. Smith, T. Malmstrom, H. Musa, P. Huettl, F. Collins, Recombinant human GDNF specifically promotes the survival and morphological differentiation of midbrain dopaminergic neurons, Soc. Neurosci. Abstr. 19 (1993) 652.
291. [291] L.-F.H. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, F. Collins, GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science 260 (1993) 1130-1132.
292. [292] L.-F.H. Lin, T.J. Zhang, D. Smith, J. Ross, L.G. Armes, F. Collins, Purification of GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Soc. Neurosci. Abstr. 19 (1993) 651.
293. [293] L.-F.H. Lin, T.J. Zhang, F. Collins, L.G. Armes, Purification and initial characterisation of rat B49 glial cell line-derived neurotrophic factor, J. Neurochem. 63 (1994) 758-768.
294. [294] N. Lindefors, P. Ernfors, T. Falkenberg, H. Persson, Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and β-nerve growth factor mRNA in rat hippocampus, Exp. Brain Res. 88 (1992) 78-90.
295. [295] N. Lindefors, E. Brodin, M. Metsis, Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus electroconvulsive shock, Neuroscience 65 (1995) 661-670.
296. [296] M.D. Lindner, S.R. Winn, E.E. Baetge, J.P. Hammang, F.T. Gentle, E. Doherty, P.E. McDermott, B. Frydel, M.D. Vilman, T. Schallert, D.F. Emerich, Implantation of encapsulated catecholamine and GDNF producing cells in rats with unilateral dopamine deletions and Parkinsonian symptoms, Exp. Neurol. 132 (1995) 62-76.
297. [297] M.D. Lindner, C.E. Kearns, S.R. Winn, B. Frydel, D.F. Emerich, Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats, Cell Transplant. 5 (1996) 205-223.
298. [298] R.M. Lindsay, Neurotrophins and receptors, Prog. Brain Res. 103 (1994) 3-14.
299. [299] R.M. Lindsay, S.J. Wiegand, C.A. Altar, P.S. DiStefano, Neurotrophic factors: from molecule to man, Trends Neurosci. 17 (1994) 182-190.
300. [300] O. Lindvall, Z. Kokaia, J. Bengzon, E. Elmer, M. Kokaia, Neurotrophins and brain insults, Trends Neurosci. 17 (1994) 490-496.
301. [301] R. Loy, M.B. Lachyankar, P.J. Condon, D.K. Poluha, A.H. Ross, Retrograde axonal transport and lesion-induced upregulation of the trkA high-affinity NGF receptor, Exp. Neurol. 130 (1994) 377-386.
302. [302] Y.J. Ma, K. Berg-von der Emde, M. Moholt-Siebert, D.F. Hill, S.R. Ojeda, Region-specific regulation of transforming growth factor α (TGFα) gene expression in astrocytes of the neuroendocrine brain, J. Neurosci. 14 (1994) 5644-5651.
303. [303] G.A. MacGibbon, P.A. Lawlor, E.S. Sirimanne, M.R. Walton, B. Connor, D. Young, C. Willimas, P. Gluckman, R.L.M. Faull, P. Hughes, M. Dragunow, Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus, Brain Res. 750 (1997) 223-234.
304. [304] P.C. Maisonpierre, L. Belluscio, S. Squinto, N.Y. Ip, M.E. Furth, R.M. Lindsay, G.D. Yancopoulos, Neurotrophin-3: a neurotrophic factor related to NGF and BDNF, Science 247 (1990) 1146-1451.
305. [305] L.M. Maness, A.J. Kastin, J.T. Webber, W.A. Banks, B.S. Beckman, J.E. Zadina, The neurotrophins and their receptors: structure, function, and neuropathology, Neurosci. Biobehav. Rev. 18 (1994) 143-159.
306. [306] H. Marquardt, M.W. Hunkapiller, L.E. Hood, D.R. Twardzik, J.E. De Larco, J.R. Stephenson, G.J. Todaro, Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino-acid sequence homology with epidermal growth factor, Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 4684-4688.
307. [307] K.A. Marshall, S.E. Daniel, N. Cairns, P. Jenner, B. Halliwell, Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy Body disease, Biochem. Biophys. Res. Commun. 240 (1997) 84-87.
308. [308] D. Martin, G. Miller, M. Rosendahl, D.A. Russell, Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat, Brain Res. 683 (1995) 172-178.
309. [309] D. Martin, G. Miller, N. Fischer, D. Dix, T. Cullen, D. Russell, Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats, Eur. J. Neurosci. 8 (1996) 1249-1255.
310. [310] A. Martinez-Serrano, A. Bjorklund, Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells, J. Neurosci. 16 (1996) 4606-4616.
311. [311] A. Martinez-Serrano, P. Horellou, W. Fischer, C. Bentiage, K. Campbell, R.D.G. McKay, J. Mallet, A. Bjorklund, CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomised cholinergic neurons after transplantation into the septum, J. Neurosci. 15 (1995) 5668-5680.
312. [312] A. Martinez-Serrano, W. Fischer, S. Soderstrom, T. Ebendal, A. Bjorklund, Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6355-6360.
313. [313] A. Martinez-Serrano, P.A. Hantzopoulos, A. Bjorklund, Ex vivo gene transfer of brain-derived neurotrophic factor to intact rat forebrain: neurotrophic effects on cholinergic neurons, Eur. J. Neurosci. 8 (1996) 727-735.
314. [314] J. Marx, NGF and Alzheimer's: hopes and fears, Science 247 (1990) 408-410.
315. [315] M.P. Mattson, S.W. Barger, B. Cheng, I. Lieberburg, V.L. Smith-Swintosky, R.E. Rydel, β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease, Trends Neurosci. 16 (1993) 409-414.
316. [316] F.A. McMorris, R.L. Mozell, M.J. Carson, Y. Shinar, R.D. Meyer, N. Marchetti, Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors, Ann. NY Acad. Sci. 692 (1993) 321-334.
317. [317] S.O. Meakin, E.M. Shooter, The nerve growth factor family of receptors, Trends Neurosci. 15 (1992) 323-330.
318. [318] S.O. Meakin, U. Suter, C.C. Drinkwater, A.A. Welcher, E.M. Shooter, The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2374-2378.
319. [319] P.W. Mesner, T.R. Winters, S.H. Green, Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons, J. Cell Biol. 119 (1992) 1669-1680.
320. [320] P.W. Mesner, C.L. Epting, J.L. Hegarty, S.H. Green, A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells, J. Neurosci. 15 (1995) 7357-7366.
321. [321] R.G. Miller, W.W. Bryan, M.A. Dietz, T.L. Musat, J.H. Petajan, S.A. Smith, J.C. Goodpasture, Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis, Neurology 47 (1996) 1329-1331.
322. [322] R.G. Miller, J.H. Petajan, W.W. Bryan, C. Armon, R.J. Barohn, J.C. Goodpasture, R.J. Hoagland, G.J. Parry, M.A. Ross, S.C. Stromatt, A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS study group, Ann. Neurol. 39 (1996) 256-260.
323. [323] E.A. Milward, R. Papadopoulos, S.J. Fuller, R.D. Moir, D. Small, K. Beyreuther, C.L. Masters, The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth, Neuron 9 (1992) 129-137.
324. [324] R.C. Miranda, F. Sohrabji, C.D. Toran-Allerand, Neuronal colocalisation of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6439-6443.
325. [325] H. Mitsumoto, K. Ikeda, T. Holmlund, T. Greene, J.M. Cedarbaum, V. Wong, R.M. Lindsay, The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neurons disease, Ann. Neurol. 36 (1994) 142-148.
326. [326] W.C. Mobley, R.L. Neve, S.B. Prusiner, M.P. McKinley, Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9811-9815.
327. [327] H. Mochizuki, K. Goto, H. Mori, Y. Mizuno, Histochemical detection of apoptosis in Parkinson's disease, J. Neurol. Sci. 137 (1996) 120-123.
328. [328] H. Mochizuki, H. Mori, Y. Mizuno, Apoptosis in neurodegenerative disorders, J. Neural Transm. 50 (1997) 125-140.
329. [329] M. Mogi, M. Harada, T. Kondo, Y. Mizuno, H. Narabayashi, P. Riederer, T. Nagatsu, bcl-2 protein is increased in the brain from Parkinsonian patients, Neurosci. Lett. 215 (1996) 137-139.
330. [330] P. Monaghan, D. Robertson, T.A.S. Amos, M.J.S. Dyer, D.Y. Mason, M.F. Greaves, Ultrastructural localization of BCL-2 protein, J. Histochem. Cytochem. 40 (1992) 1819-1825.
331. [331] C.N. Montera, F. Hefti, Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment, J. Neurosci. 8 (1987) 2986-2999.
332. [332] X. Mu, J. He, D.W. Anderson, J.Q. Trojanowski, J.E. Springer, Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons, Ann. Neurol. 40 (1996) 379-386.
333. [333] E.J. Mufson, J.H. Kordower, Cortical neurons express nerve growth factor receptors in advancing age and Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 569-573.
334. [334] E.J. Mufson, M. Bothwell, L.B. Hersh, J.H. Kordower, Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalisation with cholinergic neurons, J. Comp. Neurol. 285 (1988) 196-217.
335. [335] E.J. Mufson, M. Bothwell, J.H. Kordower, Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain, Exp. Neurol. 105 (1989) 221-232.
336. [336] E.J. Mufson, J.M. Conner, S. Varon, J.H. Kordower, Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation, J. Comp. Neurol. 341 (1994) 507-519.
337. [337] E.J. Mufson, J.S. Krion, T. Sobreviela, M.A. Burke, J.H. Kordower, R.D. Penn, J.A. Miller, Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalisation with dopamine containing substantia nigra neurons in rat, Exp. Neurol. 129 (1994) 15-26.
338. [338] E.J. Mufson, J.M. Conner, J.H. Kordower, Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis, NeuroReport 6 (1995) 1063-1066.
339. [339] E.J. Mufson, J.S. Kroin, Y.-T. Liu, T. Sobreviela, R.D. Penn, J.A. Miller, J.H. Kordower, Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localisation with substantia nigra dopamine-containing neurons, Neuroscience 71 (1996) 179-191.
340. [340] E.J. Mufson, J.M. Li, T. Sobreviela, J.H. Kordower, Decreased trkA gene expression within the basal forebrain neurons in Alzheimer's disease, NeuroReport 8 (1996) 25-29.
341. [341] K. Murase, T. Nabeshima, Y. Robitaille, R. Quirion, M. Ogawa, K. Hayashi, NGF level is not decreased in the serum, brain-spinal fluid, hippocampus or parietal cortex of individuals with Alzheimer's disease, Biochem. Biophys. Res. Commun. 193 (1993) 198-203.
342. [342] K. Murase, K. Igarashi, K. Hayashi, Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples, Clin. Chim. Acta 227 (1994) 23-36.
343. [343] L.J. Murphy, G.I. Bell, H.G. Friesen, Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat, Endocrinology 120 (1987) 1279-1282.
344. [344] K.D. Murray, C.M. Gall, E.G. Jones, P.J. Isackson, Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease, Neuroscience 60 (1994) 37-48.
345. [345] E.J. Musfon, N. Lavine, S. Jaffar, J.H. Kordower, R. Quirion, H.U. Saragovi, Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease, Exp. Neurol. 146 (1997) 91-103.
346. [346] M. Nakanishi, Gene introduction into animal tissues, Crit. Rev. Ther. Drug Carrier Syst. 12 (1995) 263-310.
347. [347] M. Narisawa-Saito, K. Wakabayashi, S. Tsuji, H. Takahashi, H. Nawa, Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease, NeuroReport 7 (1996) 2925-2928.
348. [348] H. Nawa, J. Carnahan, C. Gail, BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels, Eur. J. Neurosci. 7 (1995) 1527-1535.
349. [349] M. Nieto-Sampedro, F. Gomez-Pinilla, D.J. Knauer, J.T. Broderick, Epidermal growth factor receptor immunoreactivity in rat brain astrocytes: response to injury, Neurosci. Lett. 91 (1988) 276-282.
350. [350] A. Nitta, K. Murase, Y. Furukawa, K. Hayashi, T. Hasegawa, T. Nabeshima, Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats, Eur. J. Pharmacol. 250 (1993) 23-30.
351. [351] T. Nonomura, C. Nishio, R.M. Lindsay, H. Hatanaka, Cultured basal forebrain cholinergic neurons from postnatal rats show both overlapping and non-overlapping responses to the neurotrophins, Brain Res. 683 (1995) 129-139.
352. [352] I. Ocrant, C.T. Fay, J.T. Parmelee, Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system, Endocrinology 127 (1990) 1260-1267.
353. [353] D. Offen, I. Ziv, A. Barzilai, S. Gorodin, E. Glater, A. Hochman, E. Melemed, Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease, Neurochem. Int. 31 (1997) 207-216.
354. [354] D. Offen, I. Ziv, H. Panet, L. Wasserman, R. Stein, E. Melamed, A. Barzilai, Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2, Cell. Mol. Neurobiol. 17 (1997) 289-304.
355. [355] K. Ohnishi, H. Tomimoto, I. Akiguchi, N. Seriu, T. Kawamata, S. Nakamura, J. Kimura, T. Nishio, K. Higuchi, M. Hosokawa, Age-related decrease of nerve growth factor-like immunoreactivity in the basal forebrain of senescence-accelerated mice, Acta Neuropathol. 90 (1995) 11-16.
356. [356] L. Olson, NGF and the treatment of Alzheimer's disease, Exp. Neurol. 124 (1993) 5-15.
357. [357] Z. Oltivai, C. Milliman, S.J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74 (1993) 609-619.
358. [358] J. Opacka-Juffry, S. Ashworth, S.P. Hume, D. Martin, D.J. Brooks, S.B. Blunt, GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET, NeuroReport 7 (1995) 348-352.
359. [359] R.W. Oppenheim, Cell death during development of the nervous system, Annu. Rev. Neurosci. 14 (1991) 453-501.
360. [360] D.W. Oppenheim, Y. Qin-Wei, D. Prevette, Q. Yan, Brain-derived neurotrophic factor rescues developing avian motor neurons from cell death, Nature 360 (1992) 755-757.
361. [361] A. Pandiella, L. Beguinot, L.M. Vicentini, J. Meldolesi, Transmembrane signalling at the epidermal growth factor receptor, Trends Neurosci. 10 (1989) 411-414.
362. [362] E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer, A. LeBlanc, Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons, J. Neurosci. 16 (1996) 7533-7539.
363. [363] E. Perez-Navarro, E. Arenas, J. Reiriz, N. Calvo, J. Alberch, Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage, Neuroscience 75 (1996) 345-352.
364. [364] D.A. Peterson, C.A. Luccidi-Phillips, K.L. Eagle, F.H. Gage, Perforant path damage results in progressive neuronal damage and somal atrophy in layer II of entorhinal cortex and functional impairment with increasing postdamage age, J. Neurosci. 14 (1994) 6872-6885.
365. [365] C.H. Phelps, F.H. Gage, J.H. Growdon, F. Hefti, R. Harbough, M.V. Johnston, Z. Khachaturian, W. Mobley, D. Price, M. Rasklind, J. Simpkins, L. Thal, J. Woodcock, Potential use of nerve growth factor to treat Alzheimer's disease, Neurobiol. Aging 10 (1989) 205-207.
366. [366] H.S. Phillips, J.M. Hains, G.R. Laramee, A. Rosenthal, J.W. Winslow, Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons, Science 250 (1990) 290-293.
367. [367] H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, J.W. Winslow, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron 7 (1991) 695-702.
368. [368] C.J. Pike, A.J. Walencewicz-Wasserman, J. Kosmoski, D.H. Cribbs, G.G. Glabe, C.W. Cotman, Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity, J. Neurochem. 64 (1995) 253-265.
369. [369] R.N. Pittman, S. Wang, A.J. DiBenedetto, J.C. Mills, A system for characterising cellular and molecular events in programmed neuronal cell death, J. Neurosci. 13 (1993) 3669-3680.
370. [370] C. Portera-Cailliau, J.C. Hedreen, D.L. Price, V.E. Koliatsos, Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models, J. Neurosci. 15 (1995) 3775-3787.
371. [371] C. Portera-Cailliau, D.L. Price, L.J. Martin, Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum, J. Comp. Neurol. 378 (1997) 70-87.
372. [372] D.L. Price, D.R. Borchelt, L.C. Walker, S.S. Sisodia, Toxicity of synthetic A β peptides and modeling of Alzheimer's disease, Neurobiol. Aging 13 (1992) 623-625.
373. [373] S.E. Purdon, E. Mohr, V. Ilivitsky, B.D. Jones, Huntington's disease: pathogenesis, diagnosis and treatment, J. Psychiatry Neurosci. 19 (1994) 359-367.
374. [374] R. Quirion, D.M. Araujo, P.A. Lapchak, D. Seto, J.-G. Chabot, Growth factors and lymphokines: modulators of cholinergic neurons activity, Can. J. Neurol. Sci. 18 (1991) 390-393.
375. [375] S. Rabizadeh, J. Oh, L. Zhong, J. Yang, C.M. Bitler, L.L. Butcher, D.E. Bredesen, Induction of apoptosis by the low-affinity NGF receptor, Science 261 (1993) 345-348.
376. [376] S. Rabizadeh, C.M. Bitler, L.L. Butcher, D.E. Bredesen, Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10703-10706.
377. [377] H.K. Raymon, S. Thode, F.H. Gage, Application of ex vivo gene therapy in the treatment of Parkinson's disease, Exp. Neurol. 144 (1997) 82-91.
378. [378] G.W. Rebeck, B.T. Hyman, Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease, Neurobiol. Aging 14 (1993) 45-47.
379. [379] J.C. Reed, Bcl-2 and the regulation of programmed cell death, Cell Biol. 124 (1994) 1-6.
380. [380] F.H. Reynolds, G.J. Todaro, C. Fryling, J.R. Stephenson, Human transforming growth factors induce tyrosine phosphorylation of EGF receptors, Nature 292 (1981) 259-262.
381. [381] N. Rocamora, L. Massieu, H.W. Boddeke, G. Mengod, J.M. Palacios, Neuronal death and neurotrophin gene expression: long-lasting stimulation of neurotrophin-3 messenger RNA in the degenerating CA1 and CA4 pyramidal cell layers, Neuroscience 53 (1993) 905-908.
382. [382] R.D. Rosenfeld, L. Zeni, N. Haniu, J. Talvenheimo, S.F. Radka, L. Bennett, J.A. Miller, A.A. Welcher, Purification and identification of brain-derived neurotrophic factor from human serum, Protein Express. Purificat. 6 (1995) 465-471.
383. [383] A. Rosenthal, D.V. Goeddel, T. Nguyen, E. Martin, L.E. Burton, A. Shih, G.R. Laramee, F. Wurm, A. Mason, K. Nikolics, J.W. Winslow, Primary structure and biological activity of human brain-derived neurotrophic factor, Endocrinology 129 (1991) 1289-1294.
384. [384] A.H. Ross, M.B. Lachyankar, D.K. Poluha, R. Loy, Axonal transport of the trkA high-affinity NGF receptor, Prog. Brain Res. 103 (1994) 15-22.
385. [385] M. Rossor, N.J. Garrett, A.L. Johnson, C.Q. Mountjoy, M. Roth, L.L. Iversen, A post-mortem study of the cholinergic and GABA systems in senile dementia, Brain 105 (1982) 313-330.
386. [386] P. Rotwein, S.K. Burgess, J.D. Milbrandt, J.E. Krause, Differential expression of insulin-like growth factor genes in rat central nervous system, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 265-269.
387. [387] B.N. Saffran, Should intracerebroventricular nerve growth factor be used to treat Alzheimer's disease?, Perspect. Biol. Med. 35 (1992) 471-486.
388. [388] S.M. Sagar, R.H. Edwards, F.R. Sharp, Epidermal growth factor and transforming growth factor a induce c-fos gene expression in retinal muller cells in vivo, J. Neurosci. Res. 29 (1991) 549-559.
389. [389] A.R. Saitiel, S.J. Decker, Cellular mechanisms of signal transduction for neurotrophins, BioEssays 16 (1994) 405-411.
390. [390] T. Saitoh, K. Horsburgh, E. Masliah, Hyperactivation of signal transduction systems in Alzheimer's disease, Ann. NY Acad. Sci. 640 (1991) 34-41.
391. [391] A.-C. Sandberg, C. Engberg, M. Lake, H. von Holst, V.R. Sara, The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma, Neurosci. Lett. 93 (1988) 114-119.
392. [392] M.S. Saporito, S. Carswell, High level of synthesis and local effects of nerve growth factor in the septal region of the adult rat brain, J. Neurosci. 15 (1995) 2280-2286.
393. [393] V.R. Sara, C. Carlsson-Skwirut, K. Drakenberg, M.B. Giacobini, L. Hakansson, M. Mirmiran, A. Nordberg, L. Olson, M. Reinecke, P.A. Stahlbom, A.C.S. Nordqvist, The biological role of truncated insulin-like growth factor-I and the tripeptide GPE in the central nervous system, Ann. NY Acad. Sci. 692 (1993) 183-191.
394. [394] H. Sauer, C. Rosenbald, A. Bjorklund, Glial cell line-derived neurotrophic factor but not transforming growth factor beta-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8935-8939.
395. [395] D.G. Schaar, B.-A. Sieber, C.F. Dreyfus, I.B. Black, Regional and cell-specific expression of GDNF in rat brain, Exp. Neurol. 124 (1993) 368-371.
396. [396] D.G. Schaar, B.-A. Sieber, A.C. Sherwood, D. Dean, G. Mendoza, L. Ramakrishnan, C.F. Dreyfus, I.B. Black, Multiple astrocyte transcripts encode nigral trophic factors in rat and human, Exp. Neurol. 130 (1994) 387-393.
397. [397] G.C. Schatteman, L. Gibbs, A.A. Lanahan, P. Calude, M. Bothwell, Expression of NGF receptor in the developing and adult primate central nervous system, J. Neurosci. 8 (1988) 860-873.
398. [398] P.E. Schauwecker, T.H. McNeill, Enhanced but delayed axonal sprouting of the commissural/associational pathway following a combined entorhinal cortex/fimbria fornix lesion, J. Comp. Neurol. 351 (1995) 453-464.
399. [399] R. Schmidt-Kastner, A. Tomac, B. Hoffer, S. Bektesh, B. Rosenzweig, L. Olson, Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats, Mol. Brain Res. 26 (1994) 325-330.
400. [400] R. Schmidt-Kastner, C. Wetmore, L. Olson, Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, stratum and cortex, Neuroscience 74 (1996) 161-183.
401. [401] J. Scott, M. Selby, M. Urdea, M. Quiroga, G.I. Bell, W.J. Rutter, Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor, Nature 302 (1983) 538-539.
402. [402] J. Scott, M. Selby, M. Urdea, M. Quiroga, G.I. Bell, W.J. Rutter, Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor, Nature 302 (1993) 538-540.
403. [403] S.A. Scott, E.J. Mufson, J.A. Weingartner, K.A. Skau, K.A. Crutcher, Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis, J. Neurosci. 15 (1995) 6213-6221.
404. [404] A. Seiger, A. Nordberg, H. von Holst, L. Backman, T. Ebendal, I. Alafuzoff, K. Amberia, P. Hartvig, A. Herlitz, A. Lilja, H. Lundqvist, B. Langstrom, B. Meyerson, A. Persson, M. Viitanen, B. Winblad, L. Olson, Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy, Behav. Brain Res. 57 (1993) 255-261.
405. [405] M. Seiler, M.E. Schwab, Specific retrograde transport of nerve growth factor (ngf) from neocortex to nucleus basalis in the rat, Brain Res. 300 (1984) 33-39.
406. [406] D.J. Selkoe, Amyloid protein and Alzheimer's disease, Scientific American, November 1991, 40-47.
407. [407] C. Sell, R. Baserga, R. Rubin, Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis, Cancer Res. 55 (1995) 303-306.
408. [408] M. Sendtner, B. Holtmann, R. Kolbeck, H. Thoenen, Y.A. Barde, Brain-derived neurotrophic factor prevents death of motorneurons in newborn rats after nerve section, Nature 360 (1992) 757-759.
409. [409] M. Sendtner, H. Schmalbruch, K.A. Stockli, P. Carroll, G.W. Kreutzberg, H. Thoenen, Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy, Nature 358 (1992) 502-504.
410. [410] M.-C. Senut, M.H. Tuszynski, H.K. Raymon, S.T. Suhr, N.H. Liou, K.R. Jones, L.F. Reichardt, F.H. Gage, Regional differences in responsiveness of adult CNS axons to grafts of cells expressing human neurotrophin-3, Exp. Neurol. 135 (1995) 36-55.
411. [411] K.B. Seroogy, V.K.H. Han, D.C. Lee, Regional expression of transforming growth factor-α mRNA in the rat central nervous system, Neurosci. Lett. 125 (1991) 241-245.
412. [412] K.B. Seroogy, K.H. Lundgren, D.C. Lee, K.M. Guthrie, C.M. Gall, Cellular localisation of transforming growth factor-α mRNA in rat forebrain, J. Neurochem. 60 (1993) 1777-1782.
413. [413] D.L. Shelton, L.F. Reichardt, Studies on the expression of the β nerve growth factor (β NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 2714-2718.
414. [414] S. Shimasaki, M. Shimonaka, H.-P. Zhang, N. Ling, Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human, J. Biol. Chem. 266 (1991) 10646-10653.
415. [415] S. Shimohama, Y. Tamura, A. Akaike, T. Tsukahara, O. Ohara, S. Watanabe, J. Kimura, Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons, Neurosci. Lett. 164 (1993) 55-58.
416. [416] C.W. Shults, T. Kimber, C.A. Altar, BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine, NeuroReport 6 (1995) 1109-1112.
417. [417] C.W. Shults, T. Kimber, D. Martin, Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine, NeuroReport 7 (1996) 627-631.
418. [418] J.R. Singleton, A.E. Randolph, E.L. Feldman, Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis, Cancer Res. 56 (1996) 4522-4529.
419. [419] J. Sjoberg, M. Kanje, Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve, Brain Res. 485 (1989) 102-108.
420. [420] M.H. Skup, B.C. Figueiredo, A.C. Cuello, Intraventricular application of BDNF and NT-3 failed to protect nucleus basalis magnocellularis cholinergic neurons, NeuroReport 5 (1994) 1105-1109.
421. [421] R.S. Sloviter, Calcium-binding protein (calbindin D28k) and parvalbumin immunohistochemistry: localisation in the rat hippocampus with specific reference to selective vulnerability of hippocampal neurons to seizure activity, J. Comp. Neurol. 280 (1989) 183-190.
422. [422] G. Smale, N.R. Nichols, D.R. Brady, C.E. Finch, W.E. Horton, Evidence of apoptotic cell death in Alzheimer's disease, Exp. Neurol. 133 (1995) 225-230.
423. [423] T. Sobreviela, D.O. Clary, L.F. Reichardt, M.M. Brandabur, J.H. Kordower, E.J. Mufson, TrkA-immunoreactive profiles in the central nervous system: colocalisation with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin, J. Comp. Neurol. 350 (1994) 587-611.
424. [424] M.V. Sofroniew, N.P. Galletly, O. Isacson, C.N. Svendsen, Survival of adult basal cholinergic neurons after loss of target neurons, Science 247 (1990) 338-342.
425. [425] K.H. Sonnenfeld, D.N. Ishii, Fast and slow nerve growth factor binding sites in human neuroblastoma and rat pheochromocytoma cell lines: relationship of sites to each other and to neurite formation, J. Neurosci. 5 (1985) 1717-1728.
426. [426] C. Spenger, C. Hyman, L. Studer, M. Egli, L. Evtouchenko, C. Jackson, A. Dahl-Jorgensen, R.M. Lindsay, R.W. Seiler, Effects of BDNF on dopaminergic, serotinergic and GABAergic neurons in cultures of human fetal ventral mesencephalon, Exp. Neurol. 133 (1995) 50-63.
427. [427] J.E. Springer, Experimental evidence for growth factor treatment and function in certain neurological disorders, Exp. Neurol. 124 (1993) 2-4.
428. [428] J.E. Springer, L.W. Bergmann, X. Mu, J.Q. Trojanowski, Expression of GDNF mRNA in rat and human nervous tissue, Exp. Neurol. 127 (1994) 167-170.
429. [429] J.E. Springer, B.J. Gwag, F.M. Sessler, Neurotrophic factor mRNA expression in dentate gyrus is increased following in vivo stimulation of the angular bundle, Mol. Brain Res. 23 (1994) 135-143.
430. [430] T.L. Steininger, B.H. Wainer, R. Klein, M. Barbacid, H.C. Palfrey, High-affinity nerve growth factor receptor (trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain, Brain Res. 612 (1993) 330-335.
431. [431] K.L. Stenvers, P.K. Lund, M. Gallagher, Increased expression of type I insulin-like factor receptor messenger RNA in rat hippocampal formation is associated with aging and behavioural impairment, Neuroscience 72 (1996) 505-518.
432. [432] O. Strada, E.C. Hirsch, F. Javoy-Agid, S. Lehericy, M. Ruberg, J.J. Hauw, Y. Agid, Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain, J. Neurosci. 12 (1992) 4766-4774.
433. [433] I. Stromberg, L. Bjorklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. Hoffer, C. Humpel, Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopaminergic neurons in vivo, Exp. Neurol. 124 (1993) 401-412.
434. [434] L. Studer, C. Spenger, R.W. Seiler, A. Othberg, O. Lindvall, P. Odin, Effect of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon, Exp. Brain Res. 108 (1996) 328-336.
435. [435] J.H. Su, A.J. Anderson, B.J. Cummings, C.W. Cotman, Immunohistochemical evidence for apoptosis in Alzheimer's disease, NeuroReport 5 (1994) 2529-2533.
436. [436] M.K. Sutherland, M.J. Somerville, L.K.K. Yoong, C. Bergeron, M.R. Haussler, D.R. Craaper McLochlan, Reduction of vitamin D hormone receptor mRNA levels in Alzheimer's compared to Huntington's hippocampus: correlation with calbindin-28 K mRNA levels, Mol. Brain Res. 13 (1992) 239-250.
437. [437] A. Sutter, R.J. Riopelle, R.M. Harris-Warrick, E.M. Shooter, Nerve growth factor receptors, J. Biol. Chem. 254 (1979) 5972-5982.
438. [438] L.W. Swamson, C. Kohler, A. Bjorklund, The limbic region: the septohippocampal system, Handbook of Chemical Neuroanatomy, Vol. 5, Elsevier, Amsterdam, 1987, pp. 125-277.
439. [439] G. Taglialatela, C.J. Hibbert, L.A. Hutton, K. Werrbach-Perez, J.R. Perez-Polo, Suppression of p140trkA does not abolish nerve growth factor-mediated rescue of serum-free PC12 cells, J. Neurochem. 66 (1996) 1826-1835.
440. [440] A. Takeda, H. Onodera, Y. Yamasaki, K. Furukawa, K. Kogure, M. Obinata, S. Shibahara, Decreased expression of neurotrophin-3 mRNA in the rat hippocampus following transient forebrain ischemia, Brain Res. 569 (1992) 177-180.
441. [441] S.A. Tan, N. Deglon, A.D. Zurn, E.E. Baetge, B. Bamber, A.C. Kato, P. Aebischer, Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF, Cell Transplant. 5 (1996) 577-587.
442. [442] M. Taniuchi, J.B. Schweitzer, E.M. Johnson, Nerve growth factor receptor molecules in rat brain, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 1950-1954.
443. [443] N.A. Tatton, S.J. Kish, In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining, Neuroscience 77 (1997) 1037-1048.
444. [444] A. Tham, A. Nordberg, F.E. Grission, C. Carlsson-Skwirut, M. Viitanen, V.R. Sara, Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer's type, J. Neural Transm. 5 (1993) 165-176.
445. [445] H. Thoenen, The changing scene of neurotrophic factors, Trends Neurosci. 14 (1991) 165-170.
446. [446] H. Thoenen, C. Bandtlow, R. Heumann, The physiological function of nerve growth factor in the central nervous system: comparison with the periphery, Rev. Physiol. Biochem. Pharmacol. 109 (1987) 145-178.
447. [447] H. Thoenen, F. Zafra, B. Hengerer, D. Lindholm, The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems, Ann. NY Acad. Sci. 640 (1991) 86-89.
448. [448] L.B. Thomas, D.J. Gates, E.K. Richfield, T.F. O'Brien, J.B. Schweitzer, D.A. Steindler, DNA End Labelling (TUNEL) in Huntington's disease and other neuropathological conditions, Exp. Neurol. 133 (1995) 265-272.
449. [449] A. Tomac, E. Lindqvist, L.-F.H. Lin, S.O. Orgen, D. Young, B.J. Hoffer, L. Olson, Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo, Nature 373 (1995) 335-339.
450. [450] A. Tomac, J. Widenfalk, L.-F.H. Lin, T. Kohno, T. Ebendal, B.J. Hoffer, L. Olson, Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8274-8278.
451. [451] M.M. Tompkins, E.J. Basgall, E. Zamrini, W.D. Hill, Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons, Am. J. Pathol. 150 (1997) 119-131.
452. [452] I. Torres-Aleman, F. Naftolin, R.J. Robbins, Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture, Neuroscience 35 (1990) 601-608.
453. [453] I. Torres-Aleman, S. Pons, F.F. Santos-Benito, Survival of Purkinje cells in cerebellar cultures is increased by insulin-like growth factor I, Eur. J. Neurosci. 4 (1992) 864-869.
454. [454] J.J.S. Treanor, D. Dawbarn, S.J. Allen, S.H. MacGowan, G.K. Wilcock, Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain, Neurosci. Lett. 121 (1991) 73-76.
455. [455] J.J.S. Treanor, L. Goodman, F. de Sauvage, D.M. Stone, K.T. Poulsen, C.D. Beck, C. Gray, M.P. Armanini, R.A. Pollock, F. Hefti, H.S. Phillips, A. Goddard, M.W. Moore, A. Buj-Bello, A.M. Davies, N. Asai, M. Takahashi, R. Vandlen, C.E. Henderson, A. Rosenthal, Characterization of a multicomponent receptor for GDNF, Nature 382 (1996) 80-83.
456. [456] J. Trejo, T. Massamiri, T. Deng, N.N. Dewji, R.M. Bayney, J. Heller Brown, A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene, J. Biol. Chem. 269 (1994) 21682-21690.
457. [457] D. Troost, J. Aten, F. Morsink, J.M. de Jong, Apoptosis in ALS is not restricted to motoneurons: Bcl-2 is increased in post-central gyrus, adjacent to the affected motor cortex, J. Neurol. Sci. 129 (1995) 79-80.
458. [458] D. Troost, J. Aten, F. Morsink, J. de Jong, Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus, Neuropathol. Appl. Neurobiol. 21 (1995) 498-504.
459. [459] M. Trupp, E. Arenas, M. Fainzilber, A.-S. Nilsson, B.-A. Sieber, M. Grigoriou, C. Kilkenny, E. Salazar-Grueso, V. Pachnis, U. Arumae, H. Sariola, M. Saarma, C.F. Ibanez, Functional receptor for GDNF encoded by the c-ret proto-oncogene, Nature 381 (1996) 785-789.
460. [460] T. Tsukahara, M. Takeda, S. Shimohama, O. Ohara, N. Hashimoto, Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in monkeys, Neurosurgery 37 (1995) 733-741.
461. [461] W.A. Turski, E.A. Cavalheiro, M. Schwarz, S.J. Czuzwar, Z. Kleinrok, L. Turski, Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study, Behav. Brain Res. 9 (1983) 315-335.
462. [462] M.H. Tuszynski, H. Sang, D.G. Amaral, F.H. Gage, Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration, J. Neurosci. 10 (1990) 3604-3614.
463. [463] M.H. Tuszynski, H. Sang, K. Yoshida, F.H. Gage, Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain, Ann. Neurol. 30 (1991) 625-636.
464. [464] M.H. Tuszynski, J. Roberts, M.C. Senut, F.H. Gage, Gene therapy in the adult primate brain-intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration, Gene Ther. 3 (1996) 305-314.
465. [465] A. Ullrich, J. Schlessinger, Signal transduction by receptors with tyrosine kinase activity, Cell 61 (1990) 203-212.
466. [466] A. Ullrich, A. Gray, C. Berman, T.J. Dull, Human β-nerve growth factor gene sequence highly homologous to that of mouse, Nature 303 (1983) 821-822.
467. [467] A. Ullrich, A. Gray, A.W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Francke, J. Ramachandran, Y. Fujita-Yamaguchi, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J. 5 (1986) 2503-2512.
468. [468] C.E.E.M. Van Der Zee, J. Fawcett, J. Diamond, Antibody to NGF inhibits collateral sprouting of septohippocampal fibers following entorhinal cortex lesion in adult rats, J. Comp. Neurol. 326 (1992) 91-100.
469. [469] J.L. Venero, B. Knusel, K.D. Beck, F. Hefti, Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration, Neuroscience 59 (1994) 797-815.
470. [470] J.L. Venero, F. Hefti, K.D. Beck, Retrograde transport of nerve growth factor from hippocampus and amygdala to trkA messenger RNA expressing neurons in paraventricular and reuniens nuclei of the thalamus, Neuroscience 64 (1995) 855-860.
471. [471] J.L. Venero, F. Hefti, B. Knusel, Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration, Mol. Pharmacol. 49 (1996) 303-310.
472. [472] B.H. Wainer, Neurotrophic factors and Alzheimer's disease, Neurobiol. Aging 10 (1989) 540-542.
473. [473] H. Werner, M. Woloschak, M. Adamo, Z. Shen-Orr, C.T. Roberts, D. LeRoith, Developmental regulation of the rat insulin-like growth factor I receptor gene, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7451-7455.
474. [474] C. Wetmore, P. Ernfors, H. Persson, L. Olson, Localisation of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridisation, Exp. Neurol. 109 (1990) 141-152.
475. [475] C. Wetmore, Y. Cao, R.F. Pettersson, L. Olson, Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualised with anti-peptide antibodies, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9843-9847.
476. [476] S.R. Whittemore, T. Ebendal, L. Larkfors, L. Olson, A. Seiger, I. Stromberg, H. Persson, Developmental and regional expression of β nerve growth factor messenger RNA and protein in the rat central nervous system, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 817-821.
477. [477] S.R. Whittemore, A. Seiger, The expression, localisation and functional significance of β-nerve growth factor in the central nervous system, Brain Res. Rev. 12 (1987) 439-464.
478. [478] H.R. Widmer, T. Alexi, J. Valverde, B. Knusel, F. Hefti, TGFα stimulation of phosphatidylinositol hydrolysis in mesencephalic cultures requires neuron-glia interactions, NeuroReport 4 (1993) 407-410.
479. [479] J.N. Wilcox, R. Derynck, Localisation of cells synthesizing transforming growth factor-α mRNA in the mouse brain, J. Neurosci. 8 (1988) 1901-1904.
480. [480] B.J. Wilcox, M.D. Applegate, C. Portera-Cailliau, V.E. Koliatsos, Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons, J. Comp. Neurol. 359 (1995) 573-585.
481. [481] L. Williams, R.S. Varon, G.M. Peterson, K. Wictorin, W. Fischer, A. Bjorklund, F.H. Gage, Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9231-9235.
482. [482] L.R. Williams, G. Inouye, V. Cummins, M.A. Pelleymounter, Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor, J. Pharmacol. Exp. Ther. 277 (1996) 1140-1151.
483. [483] J. Winkler, L.J. Thal, Clinical potential of growth factors in neurological disorders, CNS Drugs 2 (1994) 465-478.
484. [484] F. Yamaguchi, T. Itano, O. Miyamoto, N.A. Janjua, T. Ohmoto, K. Hosokawa, O. Hatase, Increase in extracellular insulin-like growth factor 1 (IGF-1) concentration following electrolytical lesion in rat hippocampus, Neurosci. Lett. 128 (1991) 273-276.
485. [485] Q. Yan, J. Elliott, W.D. Snider, Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death, Nature 360 (1992) 753-755.
486. [486] Q. Yan, M.J. Radeke, C.R. Matheson, J. Talvenheimo, A.A. Welcher, S.C. Feinstein, Immunocytochemical localization of TrkB in the central nervous system of the adult rat, J. Comp. Neurol. 378 (1997) 135-157.
487. [487] J. Yeh, K.M. Rosen, L. Villa-Komaroff, Messenger ribonucleic acid for transforming growth factor-α, but not for epidermal growth factor, is expressed in fetal and neonatal mouse brain, Am. J. Obstet. Gynecol. 167 (1992) 242-245.
488. [488] X.M. Yin, Z.N. Oltvai, S.J. Korsmeyer, BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature 369 (1994) 321-323.
489. [489] Y. Yoshimoto, Q. Lin, T.J. Collier, D.M. Frim, X.O. Breakefield, M.C. Bohn, Astrocytes retrovirally transduced with BDNF elicit behavioural improvement in a rat model of Parkinson's disease, Brain Res. 691 (1995) 25-36.
490. [490] Y. Yoshiyama, T. Yamada, K. Asanuma, T. Asahi, Apoptosis related antigen, Le(Y) and nick-end labeling are positive to motor neurons in amyotrophic lateral sclerosis, Acta Neuropathol. 88 (1994) 207-211.
491. [491] S.G. Younkin, Evidence that A β42 is the real culprit in Alzheimer's disease, Ann. Neurol. 37 (1995) 287-288.
492. [492] D.M. Yurek, W. Lu, S. Hipkens, S.J. Wiegand, BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons, Exp. Neurol. 137 (1996) 105-118.
493. [493] F. Zafra, E. Castren, H. Thoene, D. Lindholm, Interplay between glutamate and γ-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10037-10041.
494. [494] S. Zeitlin, J.P. Liu, D.L. Chapman, V.E. Papaioannou, A. Efstratiadis, Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue, Nat. Genet. 11 (1995) 155-163.
495. [495] L.-T. Zhong, T. Sarafian, D.J. Kane, A.C. Charles, S.P. Mah, R.H. Edwards, D.E. Bredesen, bcl-2 inhibits death of central neural cells induced by multiple agents, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4533-4537.
496. [496] X.F. Zhou, R.A. Rush, Localisation of neurotrophin-3-like immunoreactivity in the rat central nervous system, Brain Res. 643 (1994) 162-172.
497. [497] X.-F. Zhou, L.F. Parada, D. Soppet, R.A. Rush, Distribution of trkB tyrosine kinase immunoreactivity in the rat central nervous system, Brain Res. 622 (1993) 63-70.
498. [498] C.Z. Zhu, R.N. Auer, Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia, J. Cereb. Blood Flow Metab. 14 (1994) 237-242.
499. [499] I. Ziv, A. Barzilai, D. Offen, N. Nardi, E. Melamed, Nigrostriatal neuronal death in Parkinson's disease - a passive or an active genetically-controlled process?, J. Neural Transm. 49 (1997) 69-76.
500. [500] B.V. Zlokovic, M.L.J. Apuzzo, Cellular and molecular neurosurgery: pathways from concept to reality: II. Vector systems and delivery methodologies for gene therapy of the central nervous system, Neurosurgery 40 (1997) 805-813.